A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Proellex Following Single Oral Dose Administration in Healthy Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2014
At a glance
- Drugs Telapristone (Primary)
- Indications Endometriosis; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 23 Jul 2009 Status changed from recruiting to completed.
- 16 Jul 2009 Planned end date changed from 1 May 2009 to 1 Jun 2009 as reported by ClinicalTrials.gov.
- 27 Apr 2009 New trial record